The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 5.20 — safe zoneOK
Leadership changes
From SOLENO THERAPEUTICS INC's own filings, the day they're filed.
- Jennifer Fulk · Chief Financial Officer · appointmenteff. 2026-02-25
- Dawn C. Bir · director · departureeff. 2024-08-13
- Michigan State University College · director · appointmenteff. 2023-08-15
Latest filings
- 8-K · Company announcement2026-05-18
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-04-07
- 8-K · Company announcement2026-04-06
- 8-K · Company announcement2026-03-16
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about SOLENO THERAPEUTICS INC, every answer cited🔒
- The Intelligence Brief — added when SOLENO THERAPEUTICS INC's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.